BioAzure to sell Repligen products in India
India | News | By BioSpectrum Bureau | 0 Comment | 07 Dec, 2012
Singapore: BioAzure Technologies the exclusive distribution partner for US-based Repligen has launched an enhanced line ...Read more
One third of world's unimmunized children in India
India | News | By BioSpectrum Bureau | 0 Comment | 29 Apr, 2014
Singapore: Marking the start of the World Immunization Week, the Hilleman Laboratories, an equal joint-venture partnersh...Read more
APAC witnesses boom in biotech investment: GlobalData
India | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Mar, 2014
Singapore: Asia-Pacific (APAC) region is experiencing a significant boom in the volume of private equity (PE) and ventur...Read more
Indian Pharma Convention kick starts in Sept
India | News | By BioSpectrum Bureau | 0 Comment | 18 Jul, 2013
Mumbai: Indian Drug Manufacturers' Association (IDMA) along with Association of Pharmaceutical Analysts (APA) are organi...Read more
Quintiles gets CAP's first-ever Asia accreditation
India | News | By BioSpectrum Bureau | 0 Comment | 17 Jan, 2013
Mumbai: Quintiles announced that its central laboratory in Mumbai, India, has received accreditation from the College o...Read more
LeadInvent: Taking technology to drug research
India | News | By BioSpectrum Bureau | 0 Comment | 16 Mar, 2012
A team of scientists working since 2002 at the Supercomputing Facility for Bioinformatics and Computational Biology at t...Read more
Mylan launches women care products in India
India | News | By BioSpectrum Bureau | 0 Comment | 27 Jun, 2013
Mumbai: US-based Mylan's subsidiary, Mylan Pharmaceuticals, India, has launched a portfolio of women's care products in ...Read more
Debate over compulsory licensing of Bayer's Nexavar
India | Regulatory | By BioSpectrum Bureau | 4 Comment | 30 Apr, 2012
Thecase of Indian pharma company's request for a compulsory license to make a generic version of Bayer's patented drug t...Read more
India biopharma revenues rise to $2.5 bn
India | Analysis | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2012
The domestic biopharmaceuticals business saw a significant rise in its revenues to $1.3 billion during 2011-12, accounti...Read more
Glenmark-MSD patent suit put on hold by Indian HC
India | News | By BioSpectrum Bureau | 0 Comment | 02 Aug, 2013
Singapore: In what looked like a patent suit that could stir further controversy about patenting in the life sciences in...Read more
Super-rapid diagnosis of dengue now possible
India | News | By BioSpectrum Bureau | 0 Comment | 02 Nov, 2012
New Delhi: Dr Shama Bhat, CMD, Bhat Biotech, a Bangalore based diagnostic company, has said that rapid diagnostic tests ...Read more
XCode decodes DNA, wins BioSpectrum award
India | Influencers | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2013
Dr Saleem Mohammad, who founded XCode Life Sciences in December 2010, first had the idea of starting this company while ...Read more
Indian Thyroid Society recommends TSH screening
India | News | By BioSpectrum Bureau | 0 Comment | 25 Jan, 2013
Bangalore: The Indian Thyroid Society (ITS), which has been executing various initiatives throughout the year to create ...Read more
Dr Vijay Datla to get FABA award at BioAsia 2013
India | News | By BioSpectrum Bureau | 0 Comment | 30 Jan, 2013
Hyderabad: Dr Vijay Kumar Datla, chairman and managing director of Biological E, will be given FABA Special Award 2013 ...Read more
Indian PM unveils science & technology policy
India | News | By BioSpectrum Bureau | 0 Comment | 03 Jan, 2013
New Delhi: The Indian Prime Minister, Dr Manmohan Singh, unveiled the country's science, technology and innovation polic...Read more
Deep in debt Elder Pharma decides to sell itself
India | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2013
Singapore: India-based Elder Pharmaceuticals is said to be up for sale, according to a report published in the Economic ...Read more
Sun Pharma settles patent suit with Wyeth for $414 mn
India | News | By BioSpectrum Bureau | 0 Comment | 12 Aug, 2013
Singapore: Indian pharma giant Sun Pharmaceutical Industries has said that it will be paying its dues of $414.65 million...Read more
Sanofi declares results of Lantus clinical trial
India | News | By BioSpectrum Bureau | 0 Comment | 12 Jun, 2012
Bangalore: The results of the landmark ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial showed that L...Read more